Although alterations of several genes (such as Hebp1, Eno1, and Taf9) other than Ankrd52 are more frequently detected in our tumor profiling, their targeting sgRNAs exhibited much less enrichment or fold-change as compared to those of Ankrd52 (Supplementary Fig. 3e; Supplementary Data 1). This evidence concerns the gene TAF9 and neoplasm.